
A collaboration between Swiss antibody therapeutics firm Humab BioMed and the University of California, Berkeley has given rise to an …

Takeda announced that it had completed the enrolment for the largest clinical trial in its history, having enrolled 20,100 children …

Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …

Takeda have announced plans to spend more than €100 million in the construction of a new manufacturing plant in Singen, …

Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) …

Sanofi Pasteur, the vaccines unit of the wider French firm, has announced that its dengue vaccine Dengvaxia has secured market …

Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …

Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …
Sun Pharmaceuticals (BSE: 85715) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) are set to team up to …

Sanofi, along with its vaccines global business unit Sanofi Pasteur, has announced the beginning of the first public dengue immunisation …